tiprankstipranks
Trending News
More News >
Climb Bio, Inc. (CLYM)
NASDAQ:CLYM
US Market

Compare Climb Bio (CLYM) vs. Competitors

Compare
673 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Climb Bio
$5.05
$344.33M
-6.73
170.05%
3 Buy
0 Hold
0 Sell
Strong Buy
Agenus
$2.89
$98.28M
-1.36
-17.43%
1 Buy
0 Hold
0 Sell
Moderate Buy
TuHURA Biosciences
$0.46
$28.16M
-0.71
-90.51%
2 Buy
0 Hold
0 Sell
Moderate Buy
Ovid Therapeutics
$1.48
$192.67M
-2.90
123.23%
8 Buy
0 Hold
0 Sell
Strong Buy
Cognition Therapeutics
$1.03
$90.92M
-2.17
64.01%
2 Buy
0 Hold
0 Sell
Moderate Buy
Tevogen Bio Holdings
$0.32
$56.51M
-1.58
-80.95%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CLYM
Climb Bio
5.05
3.30
188.57%
AGEN
Agenus
2.89
-0.85
-22.73%
HURA
TuHURA Biosciences
0.46
-4.00
-89.62%
OVID
Ovid Therapeutics
1.48
0.78
112.34%
CGTX
Cognition Therapeutics
1.03
0.39
60.94%
TVGN
Tevogen Bio Holdings
0.28
-1.14
-80.28%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts